A small-molecule thrombin receptor (PAR-1) antagonist blocks thrombosis in non-human primates.

被引：0
|
作者：
Andrade-Gordon, P
Derian, CK
Damiano, BP
D'Andrea, MR
Addo, MF
Darrow, AL
Nedelman, M
Zhang, HC
Maryanoff, BE
机构：
[1] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
[2] Primedica Corp, Worcester, MA USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
175
引用
收藏
页码：44A / 44A
页数：1
相关论文
共 50 条
  • [41] Thrombin receptor (PAR-1) cleavage inducer protein kinase C β-1 activation In human skeletal muscle in vitro.
    Mbebi, C
    Doyennette, MA
    Hantal, D
    Verdiére-Sahuqué, M
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 365A - 365A
  • [42] THROMBIN INDUCED APOPTOSIS IS PROTEASE ACTIVATED RECEPTOR (PAR)-3/-4 DEPENDENT IN HUMAN PODOCYTES AND PAR-1/-4 DEPENDENT IN RAT PODOCYTES
    Sharma, Ruchika
    Waller, Amanda
    Guess, Adam
    Agrawal, Shipra
    Isermann, Berend
    Smoyer, William
    Nieman, Marvin
    Kerlin, Bryce
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 28 - 28
  • [43] Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates
    Cossette, Chantal
    Miller, Lisa A.
    Ye, Qiuji
    Chourey, Shishir
    Reddy, Chintam Nagendra
    Rokach, Joshua
    Powell, William S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (02) : 322 - 336
  • [44] Tritiated photoactivatable analogs of the native human thrombin receptor (PAR-1) agonist peptide, SFLLRN-NH2
    Elliott, JT
    Hoekstra, WJ
    Derian, CK
    Ahern, DG
    Addo, MF
    Maryanoff, BE
    Prestwich, GD
    JOURNAL OF PEPTIDE RESEARCH, 2001, 57 (06): : 494 - 506
  • [45] Improving antiplatelet therapy for atherothrombotic disease - Preclinical and clinical results with SCH 530348, the first oral thrombin receptor antagonist selective for PAR-1
    Hildemann, S. K.
    Bode, C.
    HAMOSTASEOLOGIE, 2009, 29 (04): : 349 - 355
  • [46] Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain
    Takasaki, Ichiro
    Ogashi, Haruna
    Okada, Takuya
    Shimodaira, Ayaka
    Hayakawa, Daichi
    Watanabe, Ai
    Miyata, Atsuro
    Kurihara, Takashi
    Gouda, Hiroaki
    Toyooka, Naoki
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [47] A novel monovalent FGFR1 antagonist: Preclinical safety profiles in rodents and non-human primates
    Yu, Ping
    Knippel, Anja
    Onidi, Manuela
    Paoletti, Andrea
    Vigna, Enrico
    Hellmann, Juergen
    Esdar, Christina
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 406
  • [48] Efficacy of novel small molecule GLP-1 receptor agonist AZD0186 on glucose stimulated insulin secretion in obese, male non-human primates
    Wallenius, K.
    Van Zuydam, N. R.
    Boianelli, A.
    Davies, G. R.
    Brighton, C. A.
    Wergeni, A. Traff
    Eckernas, D.
    Persson, M.
    Omar, S.
    Pettersen, D.
    Lundqvist, S. A. E.
    Jurva, U.
    Snijder, A.
    Polla, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S317 - S318
  • [49] Protein kinase C-δ (PKC-δ) in human platelets is phosphorylated in response to thrombin, but not in response to the thrombin receptor (PAR-1) agonist peptide, SFLLRN
    Henriksen, RA
    FASEB JOURNAL, 1999, 13 (07): : A1578 - A1578
  • [50] Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line
    Weinstein, JR
    Lau, AL
    Brass, LF
    Cunningham, DD
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (03) : 1034 - 1050
12345